share_log

Recap: Novozymes Q4 Earnings

Benzinga ·  Feb 1 09:30

Novozymes (OTC:NVZMY) reported its Q4 earnings results on Thursday, February 1, 2024 at 03:00 AM.

Here's what investors need to know about the announcement.

Earnings

Novozymes missed estimated earnings by 18.18%, reporting an EPS of $0.36 versus an estimate of $0.44.

Revenue was up $58.13 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 2.66% increase in the share price the next day.

Here's a look at Novozymes's past performance:

QuarterQ3 2023Q2 2023Q1 2023Q4 2022
EPS Estimate0.420.420.440.41
EPS Actual0.490.320.410.43
Revenue Estimate634.28M632.02M662.60M671.94M
Revenue Actual650.51M616.52M666.31M606.10M

To track all earnings releases for Novozymes visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment